Tectonic Therapeutic, Inc.
NASDAQ:TECXBiotechnology
-$0.29 today
- Market cap
- $411.32M
- Beta
- 1.22
- P/E (TTM)
- -6.7
- EPS (TTM)
- -$4.45
Volume 0.17M
Average 0.20M
TECX Total Liabilities
Everything the company owes to creditors and other parties.
Tectonic Therapeutic, Inc.NASDAQ: TECX
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 17.2% from a year ago
Total liabilities stood at $16.16M at the end of Q1 FY2026, up 17.2% from a year earlier and up 66.4% from the prior quarter. Over 3 fiscal years it compounded at -52.9% a year.
Context
- Total liabilities amounted to 6.6% of total assets at the end of Q1 FY2026, up 2.2 pp from a year earlier.
- Total liabilities increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +17.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 9.71M USD
- Year-over-year change
- -20.0%
- 4-year CAGR
- -32.9%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.71M | -20.0% |
| FY2024 | 2024-12-31 | 12.13M | -90.2% |
| FY2023 | 2023-12-31 | 124.04M | +33.6% |
| FY2022 | 2022-12-31 | 92.86M | +94.1% |
| FY2021 | 2021-12-31 | 47.84M | — |
Total Liabilities vs competitors
How TECX compares with its peers on the latest reported figures
- TECX's Mar 2026 total liabilities of $16.16M is the lowest of the 4 companies compared; the peer median is $110.94M.
- Its year-over-year change of +17.2% is the 2nd highest of 3, against a peer median of +24.0%.
- Total liabilities amounts to 6.6% of total assets for TECX, versus a peer median of 17.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
SEPNSepterna, Inc. | Sep 2026 | $191.48M | -12.1% | +38.7% | 30.9% |
GENBGenerate Biomedicines, Inc. | Mar 2026 | $110.94M | — | — | 17.7% |
| Jun 2026 | $71.01M | +60.1% | -31.8% | 5.0% | |
TECXTectonic Therapeutic, Inc. | Mar 2026 | $16.16M | +17.2% | -52.9% | 6.6% |
| Peer median (excluding TECX) | $110.94M | +24.0% | +3.4% | 17.7% | |
Competitors are the stored peer set for TECX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 28.06M | 35.97M | 28.77M | 141.24M | 253.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 557K | 1.08M | 2.12M | 5.62M | 3.56M |
| Total Current Assets | 28.62M | 37.04M | 30.88M | 146.86M | 257.36M |
| Property, Plant & Equipment (Net) | 3.66M | 9.55M | 7.23M | 5.31M | 2.55M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 587K | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 599K | 613K | 1.29M | 156K | 1.13M |
| Total Non-current Assets | 4.26M | 10.17M | 8.52M | 6.05M | 3.68M |
| Total Assets | 32.88M | 47.21M | 39.4M | 152.91M | 261.04M |
| Account Payables | 1.81M | 574K | 409K | 976K | 1.09M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.76M | 2.66M | 33.37M | 3.59M | 4.11M |
| Total Current Liabilities | 4.12M | 7.84M | 40.89M | 11.61M | 9.67M |
| Long-term Debt | 0 | 0 | 0 | 0 | 43K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 43.02M | 80.68M | 80.63M | 0 | 0 |
| Total Non-current Liabilities | 43.72M | 85.03M | 83.15M | 519K | 43K |
| Total Liabilities | 47.84M | 92.86M | 124.04M | 12.13M | 9.71M |
| Common Stock | 0 | 0 | 0 | 2K | 2K |
| Retained Earnings | (15.6M) | (47.78M) | (90.6M) | (148.59M) | (222.74M) |
| Accumulated OCI | 0 | 0 | (11K) | 9K | (96K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (14.96M) | (45.65M) | (84.64M) | 140.78M | 251.33M |
| Total Debt | 1.06M | 5.79M | 4.34M | 3.3M | 1.28M |
| Net Debt | (27.01M) | (30.17M) | (24.43M) | (137.94M) | (252.52M) |
Tectonic Therapeutic, Inc.
NASDAQ:TECX
Intrinsic Alpha fair value
Locked
Current Price
$21.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.